Quan Wan

机构：Jiangnan University, Qingdao University of Science and Technology, Wuhan University of Technology, Wuxi No.2 People's Hospital, Zhejiang Provincial People's Hospital, China XD Group (China), Wuxi Institute of Technology · ORCID：0000-0002-9634-9885

发表论文 43 篇 · 总被引 761 次 · h-index 17

代表论文

• TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance (2022 · Cancer Research · 被引 45)
• Recent advances of CREKA peptide-based nanoplatforms in biomedical applications (2023 · Journal of Nanobiotechnology · 被引 44)
• Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma (2022 · Cell Death Discovery · 被引 29)
• SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization (2022 · Advanced Science · 被引 22)
• Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation (2024 · Molecular Biology Reports · 被引 17)
• The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity (2022 · Clinical and Translational Medicine · 被引 17)